-
-
-
Ki-Suck Jung
President, APSR 2022
Local Congress Committee
Professor, Hallym University College of Medicine -
Jae Jeong Shim
Secretary General, APSR 2022
Local Congress Committee
Professor, Korea University College of Medicine -
Jang-Won Sohn
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Hanyang University College of Medicine -
Kwang Ha Yoo
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Konkuk University School of Medicine -
Chin Kook Rhee
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, The Catholic University of Korea College of Medicine
-
Speaker's Highlight
-
-
Don Sin
University of British Columbia, St. Paul Hospital (Canada)
Kenneth R. Chapman
Toronto General Hospital Research Institute (Canada)
-
Parameswaran Nair
McMaster University (Canada)
Carolyn Calfee
UCSF (U.S.A.)
-
Gregory P. Downey
University of Colorado School of Medicine (U.S.A.)
David A. Schwartz
University of Colorado School of Medicine (U.S.A.)
-
Neil Schluger
Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
Nick Kim
Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
-
Nicola Hananiah
Baylor College of Medicine (U.S.A.)
Jae-Joon Yim
Seoul National University College of Medicine (Republic of Korea)
-
Koichiro Asano
Tokai University School of Medicine (Japan)
Diahn-Warng Perng
Taipei Veterans General Hospital (Taiwan)
-
Konstantinos Kostikas
University of Ioannina (Greece)
Karin Klooster
University Medical Center Groningen (Kingdom of the Netherlands)
-
Advanced imaging techniques for evaluating small airways disease
Small airways disease affects the terminal bronchioles and transitional zone, where inflammation, mucus, fibrosis and loss of elastic recoil can restrict airflow. Cough, wheeze and exertional breathlessness may appear before spirometry becomes abnormal, particularly in early asthma, COPD or post-transplant bronchiolitis obliterans. Imaging offers a way to identify structural change and regional ventilation that physiology alone cannot localise.
Modern assessment combines high-resolution CT with expiratory acquisitions, quantitative analysis, functional MRI and selected airway-based techniques. The useful question is whether an imaging method answers a defined clinical problem, integrates with lung function and changes management without adding avoidable radiation, cost or uncertainty.
Why small airway injury is often missed
Airway injury can be patchy and peripheral, beyond the reach of routine bronchoscopy. A patient may have a normal FEV1 and preserved FEV1/FVC while gas trapping, mosaic attenuation or subtle airway-wall thickening already indicate disease. Reduced FEF25–75 may support suspicion, but it is effort-dependent and not a direct measure of small-airway structure.
Australian exposure patterns add context: vaping and cigarette smoke are common everyday risks, while bushfire smoke in NSW and Victoria and farm dust in inland NSW and Queensland can produce repeated airway irritation. These factors can coexist with asthma, occupational lung disease or transplant-related disease, so image findings should be interpreted against exposure and treatment history rather than treated as a stand-alone diagnosis.
What advanced imaging can reveal
High-resolution computed tomography uses thin sections to show bronchi, bronchioles, lung attenuation and air trapping. Paired inspiratory and expiratory images may reveal areas that fail to empty, while prone acquisitions help distinguish dependent atelectasis from true small-airway change. CT does not directly resolve every affected bronchiole, so indirect signs must be interpreted with appropriate caution.
Quantitative CT software compares attenuation and lung volume between breaths, often using a −950 HU threshold to map persistent air trapping. Automated airway segmentation, tree-in-bronchioles and radiomics can increase consistency, although scan protocols, reconstruction settings, software and patient selection affect results. Algorithms also require validation in Australian populations before their measurements can be treated as reliable.
Functional MRI with hyperpolarised xenon-129 can depict ventilation and gas exchange without ionising radiation, but access, cost and specialised interpretation limit routine use. Endobronchial optical coherence tomography offers high-resolution views of proximal airway walls, while dynamic CT and SPECT/CT provide alternative ways to assess regional ventilation. Bronchoscopic methods cannot reach the most peripheral airways comprehensively.
Pairing imaging with pulmonary function
Pulmonary function remains the clinical anchor. Spirometry, bronchodilator response, FVC, RV/TLC and diffusion capacity show whether imaging has physiological relevance; DLCO can remain normal in isolated small-airway disease. Because small-airway flow indices vary with age and effort, serial tests and symptom response often carry more weight than one borderline value.
A combined report should state the clinical indication, technique, radiation exposure, affected lung regions, likely pattern and major alternatives. Comparison with prior CT, medication changes and recent exacerbations can prevent air trapping from being mislabelled as progression. Where advanced MRI or bronchoscopy is proposed, its incremental value should be clear before referral.
Australian access, regulation and exchange
Specialist imaging is concentrated in metropolitan Melbourne, Sydney, Brisbane and Perth, while patients in rural and remote areas may travel considerable distances. Telehealth can support discussion of scans, although it cannot replace onsite CT, pulmonary function testing or procedures. In Tasmania, the Northern Territory and regional WA, access often depends on visiting services and limited local radiology capacity.
The Australian market mixes public hospitals, Medicare-subsidised imaging, private providers and out-of-pocket fees. Bulk-billing is available for some services, but eligibility and rebates do not guarantee no costs for every scan. Referrals should consider urgency, pregnancy status, renal function where relevant, young age and whether the result is likely to alter treatment.
New scanners and clinical software may fall under the Therapeutic Goods Act 1989 and Medical Devices Regulations 2008, administered by the Therapeutic Goods Administration. Image sharing must also comply with the Privacy Act 1988 and Australian Privacy Principles; cloud analysis and My Health Record uploads require clear consent, access controls and de-identification policies.
For Australian delegates reviewing APSR 2022, the congress’s K-ETA travel guidance is one point to check when arranging travel to South Korea, alongside current airline and immigration requirements. Clinicians can use the wider meeting material to compare imaging approaches and prepare questions for respiratory specialists from different health systems.
Turning imaging into research evidence
Small-airway research improves when acquisition protocols are standardised, expiratory coverage is adequate, and outcomes are linked to symptoms, exacerbations and treatment response. Retrospective convenience samples can exaggerate the usefulness of AI or novel tracers. External validation, transparent thresholds and comparison with conventional CT remain essential.
Readers looking for additional context can consult the linked peripheral airway research site when framing a literature review or collaboration with APSR and KATRD. Current consensus guidance and local ethics, data governance and radiomics validation requirements should still guide any project.
A practical imaging checklist
Before requesting advanced imaging, the respiratory team should identify the decision the result must inform:
- Frame the request around a specific symptom or suspected diagnosis, rather than ordering broad chest imaging by default.
- Select HRCT, expiratory CT or functional MRI only when the expected finding can justify radiation, cost, sedation or travel.
- Compare quantitative air trapping with adjacent lung, reference ranges, prior scans and known technical limitations.
- Reconcile imaging with spirometry, medication exposure, smoking or vaping history, occupational contacts and recent infection.
This checklist reduces incidental findings and false certainty. It also gives radiologists the clinical context needed to distinguish small-airway disease from emphysema, asthma, infection, vascular causes of mosaic attenuation and dependent change.
Bringing imaging into respiratory care
Advanced techniques are most valuable when they answer questions that conventional tests leave open, such as why disproportionate breathlessness persists despite acceptable spirometry. They are less useful when a stable clinical problem will not change treatment. A multidisciplinary review can prevent both missed disease and unnecessary expansion of investigations.
In everyday respiratory care, the strongest small-airway assessment pairs a defined clinical question with appropriate HRCT or functional imaging, objective lung function and cautious interpretation of quantitative results. That combination turns subtle image findings into usable evidence while keeping patient safety and health-system value central.
Richard Russell
Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
-
Mona Bafadhel
King’s College London (United Kingdom)
David Jackson
Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
-
James Chalmers
University of Dundee (United Kingdom)
David Price
University of Aberdeen (United Kingdom)
-